mercredi 27 février 2013

Anticancer compounds: summary (Februar 2013) - Composés anticancéreux (février 2013)




Generic Name
Nom générique
Designation
Brand Name
Nom commercial



Abagovomab


Abexinostat (hydrochloride)
PCI-24781
CRA-024781

Abiraterone acetate
CB7630
Zytiga
Adecatumumab


Aderbasib
INCB 007839

Afatinib
BIBW2992
Tovok
Aflibercept
AVE0005
VEGF Trap
VEGF-Trap
NSC 724770
Zaltrap
Afutuzumab


Agatolimod
PF-3512676

Alacizumab


Alemtuzumab

Campath
Alisertib
MLN8237-004

Altumomab


Alvespimycin
KOS-1022

Alvespimycin hydrochloride
BMS-826476

Alvocidib
Flavopiridol
HL-275
HMR-1275
L86-8275
MDL-107826A
NSC-649890

Amatuximab
MORAb-009

Amonafide ???


Amrubicin hydrochloride
SM-5887

Amuvatinib
MP-470
MP470
HPK-56
MP470.HCl

Anamorelin hydrochloride
RC-1291 HCl

Anatumomab


Angiopoietin-2
REGN910 SAR307746

Apatinib
YN968D1

Apaziquone
EO9
EOquin, Neoquin
Apolizumab


Apricoxib
TG01
R-109339
CS-706

Arcitumomab


Astuprotimut-R
GSK-249553
SB-249553
MAGE-A3 ASCI

Axitinib
AG-13736
AG-013736

Azacitidine

Vidaza
Azacitidine 5’ elaidic ester
CP-4200

Bafetinib
INNO-406
NS-187

Balamapimod
MKI-833

Bardoxolone
RTA 401
CDDO

Bardoxolone methyl
RTA 402
CDDO-Me
NSC 713200

Bavituximab
3G4
Tarvacin
Bectumomab


Belagenpumatucel-L

Lucanix
Belimumab


Belinostat
PXD101
NSC 726630

Belotecan hydrochloride
CKD-602

Berubicin hydrochloride
RTA 744
WP744

Besilesomab


Bevacizumab

Avastin
Bivatuzumab mertansine


Blinatumomab
MEDI-538
MT-103
MT103

Bortezomib

Velcade
Bosutinib
SKI-606
PF-5208763
SKI-758

Brentuximab vedotin
SGN-35
SGN35
cAC10-vcMMAE
Adcetris
Brivanib
BMS-540215

Brivanib alaninate
BMS-582664

Cabazitaxel
XRP-6258

Cabozantinib (s-malate)
XL184
XL 184
EXEL-7184
BMS 907351

Calaspargase (pegol)
EZN-2285

Camptothecin
IT-101
CRLX101
Cyclosert-CPT
Canertinib
CI-1033

Cantuzumab mertansine


Cantuzumab ravtansine
huC242-DM4 IMGN242

Capromab pendetide


Carfilzomib
PR-171

Carlecortemcel-l

StemEX
Carlumab
CNTO 888

Catumaxomab


Cediranib (maleate)
AZD2171 (maleate)
Recentin
Cenersen sodium
OL(1)p53, EL625

Cetuximab

Erbitux
Cevipabulin (fumarate or succinate)
TTI-237

Chidamide
HBI-8000
CS055

Cilengitide
EMD 121974
EMD121974

Citatuzumab bogatox


Cixutumumab
IMC-A12

(Yttrium Y90) Clivatuzumab tetraxetan
hPAM4-DOTA
IMMU-107
90hY-PAM4

Conatumumab
AMG 655
TRAIL-R2 mAb

Contusugene ladenovec
Ad5CMV-p53
INGN 201

Cordecepin or Cordycepin
BU-01
OVI-123

Cositecan
Karenitecin

BNP1350


Crenolanib (besylate), formerly plarotinib
ARO-002(-26)
CP-868,596(-26)
CP-868596, ARO-002

Crisantaspase, Erwinia chrysanthemi L-asparaginase

Erwinase, Erwinaze (USA)
Crizotinib
PF-2341066
PF-2,341,066
PF-02341066
PF1066
PF-1066
Xalkori
Crolibulin
EPC2407

Custirsen sodium
OGX-011
ISIS 112989

Cytarabine:daunorubicin
CPX-351

Dabrafenib (mesylate)
GSK-2118436(B)

Dacetuzumab
SGN-40
huS2C6

Dacomitinib
PF-299
PF299804
PF-00299804
PF-299,804, PF00299804

Dalantercept
ACE-041

Dalotuzumab
MK-0646

Danusertib
PHA-739358

Darinaparsin
ZIO-101

Dasatinib
BMS-354825
Sprycel
Daunorubicin citrate liposome
NSC 82151
DaunoXome
DCVax-Brain

DCVax-L Brain
Decitabine

Dacogen
Defibrotide


Deforolimus
???

Degarelix acetate
FE200486
Firmagon
Delanzomib
CEP18770
CT47098
NPH007098

Demcizumab
OMP-21M18

Denenicokin
L-methionyl(human interleukin-21)
IL-21
rIL-21
recombinant human interleukin 21

Denibulin hydrochloride
MN- 029

Denosumab


Desmethyl Erlotinib
OSI-420, CP-473420

Detumomab


Dinaciclib
SCH 727965

Disomotide
MPS-22

Dovitinib
TKI258
CHIR-258

Doxorubicin (zoptarelin)
AN-152
AN 152
ZEN-008
AEZS-108
DOX-LTSL
ThermoDox
Drozitumab
PRO95780
anti-DR5
rhuMAb DR5

Dulanermin
Apo2L/TRAIL
PRO1762
TRAIL/Apo2L
AMG 951
 rhApo2L
RG3639

Dusigitumab


Ecromexumab


Edotecarin
PF-804950

Edrecolomomab


Efatutazone
CS7017
CS-7017

Elacytarabine
CP-4055
Elacyt
Elagolix
NBI-56418

Elagolix sodium
NBI-56418 Na

Elesclomol
STA-4783

Elisidepsin
PM02734
Irvalec
Elotuzumab
HuLuc63
PDL063
PDL-063
BMS-901608

Emepepimut-S
L-BLP25, BLP-25 (formerly BP1-7-KLH), EMD531444
Stimuvax
Enavatuzumab
PDL 192

Eniluracil
GW776C85
ADH300004
Cytefuran
Ensituximab
NPC-1C

Entinostat
MS275
SNDX-275
MS-275

Enzalutamide
MDVN 300 series
MDV3100

Enzastaurin
LY317615

Epetirimod mesylate
851B
S-30563-35-65

Epitinib
HMPL-813

Epratuzumab
Y90 MAb LL2, 90Y-hLL2, IMMU-103, hLL2, hCD22, AMG 412
LymphoCide Y-90
Eribulin mesylate
E7389

Erismodegib
LDE225

Erlotinib

Tarceva
Ertumaxomab


Etaracizumab
Etaratuzumab
MEDI-522
Abegrin
Vitaxin
Everolimus

Afinitor
Falimarev
PANVAC-F
CVAC-301, formerly Panvac-VF

Famitinib


Farletuzumab
MORAb-003

Ficlatuzumab
SCH900105
AV299
AV-299
SCH 900105

Figitumumab
CP-751,871

Flanvotumab
IMC-20DS7

Flumatinib
HHGV678, HH-GV678, HH-GV-678

Folitixorin calcium
ANX-510
CoFactor

Foretinib
GSK1363089G
XL880

Forodesine
BCX-1777
immucillin-H
Fodosine
Fosbretabulin (tromethamine)
combretastatin-A4 phosphate
CA4P
Zybrestat
Fostamatinib
R7935788

Fostamatinib disodium
R788
R-788
R935788 sodium

Fresolimumab
GC1008

Fruquintinib
HMPL-013

Galactomycin
GM-CT-01 (formerly Davanat-1)   
Pro-5FU
Galeterone
TOK-001
VN/124-1
VN/124
SARM/LI

Galgenprostucel-L
CG1940
GVAX™ Prostate
Galiximab


Ganetespib
STA-9090

Ganitumab
AMG 479

Gataparsen (sodium)
LY2181308 heptadecasodium salt

Gefitinib

Iressa
Gemcitabine 5'-elaidic acid ester
CP-4126
O-1.01
CO-101

Gemtuzumab ozogamicin


Girentuximab
WX-G250
cG250
anti-G250, cG250

(Iodine I124) girentuximab
124IcG250
Redectane
Givinostat
ITF2357

Glembatumumab vedotin
CR011-vcMMAE, CDX-011

Glufosfamide
D-19575

Golnerminogene pradenovec
ADgv EGR.TNF.11D

Histrelin
Formerly RL0903
Vantas
Ibritumomab tiuxetan


Icotinib
BPI-2009-H

Icrucumab
IMC-18F1
IMC18F1
LY3012212

Igovomab


Imatinib


Imatinib Mesylate
STI-571, STI571, formerly CGP-57148B
Gleevec (USA, Canada, Israel), Glivec (Europe)
Imetelstat
GRN163L
formerly GRN719

Imgatuzumab


Inalimarev
PANVAC-V
CVAC-301, formerly Panvac-VF

Indatixumab ravtansine


Indibulin
ZIO-301
D-24851

Indisulam
E7070

Ingenol mebutate
PEP-005

Intedanib
BIBF1120

Intetumumab
CNTO-95
CNTO 095
CNTO 95

Iniparib
BSI-201

Inotuzumab ozogamicin


Interferon-alpha 2b

Biphasix
Iobenguane I 131
MIP-120T, Ultratrace MIBG
Azedra, Ultratrace iobenguane I-131
Ioflubenzamide I131
BA-100
MIP-1145

Ipilimumab
MDX-010
MDX-CTLA-4
Yervoy
Iratumumab
MDX-060

Irosustat
BN83495
STX64
667 Coumate

Ispinesib
SB-715992

Labetuzumab


Lansoprazole

PrevOnco
Lapatinib (ditosylate)
572016, GW572016, GW 572016, GSK 572016
Tykerb (USA, EU), Tyverb
Lapuleucel-T
APC8024, BA7072, DN24-02
Neuvenge
Laromustine
VNP40101M, 101M

Lenalidomide
CDC501, CDC-501, CDC-5013, CC5013, CC-5013
Revlimid (formerly Revimid), Lenalidomide-Celgene Europe
Lenvatinib
ER-203492-00

Lenvatinib mesylate
E7080


Lestaurtinib
CEP-701
KT-5555

Leukocyte interleukin injection

Multikine
Leuprolide acetate

Enanton
Lexatumumab


Lexibulin
CYT997

Linifanib
ABT-869
RG3635

Linsitinib
OSI-906
OSI-906AA

Lintuzumab


Litronesib
LY2523355
KF89617

Lonafarnib
SCH66336

Lonaprisan
ZK 230211

Lorvotuzumab mertansine
huN901-DM1, BB-10901TAP, BB-10901, IMGN901

Lucatumumab
CHIR-12.12
HCD-122

Lumiliximab


Mapatumumab


Marizomib
NPI-0052

Masitinib (mesylate)
Masivet
AB1010

Matuzumab


Melphalan

Percutaneous Hepatic Perfusion (PHP)
Milatuzumab
IMMU-115

Mitumomab


Mituprotimut-T
Id/KLH

Mocetinostat
MGCD0103

Mocetinostat dihydrobromide


Mogamulizumab
KW-0761
KM8761

Motesanib (diphosphate)
AMG-706
AMG706

Moxetumomab pasudotox
CAT-8015
HA22

Mubritinib
TAK165

Nacolomab tafenatox


Naptumomab estafenatox


Narnatumab
IMC-RON8
IMC RON-8
RON8

Navitoclax dihydrochloride
ABT-263
RG7423
A-855071.0

Necitumumab
IMC-11F8

Neratinib
HKI-272
PF-05208767

Nesvacumab


Nilotinib
AMN-107
Tasigna
Nimotuzumab


Niraparib
MK-4827

Nivolumab


Nofetumomab merpentan


Obatoclax
GX15-070

Obinutuzumab
Ro-5072759
 huMAB
GA-101
Afutuzumab

Ocaratuzumab


Ofatumumab
GSK1841157
HuMax-CD20
2F2

Olaparib
AZD2281
KU-0059436

Olaratumab
IMC-3G3
IMC3G3

Omacetaxine mepesuccinate
CGX-635
Homoharringtonine

Onartuzumab
PRO143966
MetMAb
RG3638

Oportuzumab monatox


Oregovomab

OvaRex
Orteronel
TAK-700

Oxaliplatin (L-OHP)
1670RB, RP 54780
Eloxatin, Eloxatine, Elplat
Paclitaxel
ANG1005
GRN1005
MBT-0206
EndoT-1
OncoJan
EndoTAG-1
Palifosfamide
IPM
ZIO-201

Panitumumab

Vectibix
Panobinostat
LBH-589
LBH 589
LBH589
NVP-LBH589
LBH489B
LBH489A

Parsatuzumab


Patritumab


Pazopanib

Votrient
Pegdinetanib
BMS-844203
CT-322
CT322
Adnectin, Angiocept, formerly TriNectin
Pelitinib
EKB-569

Pemtumomab


Perifosine
KRX-0401
D-21266

Pertuzumab
RG1273
R1273
2C4
rhuMAb-2C4
Perjeta (formerly Omnitarg)
Pictilisib
GDC-0941

Pidilizumab


Pintumomab


Pixantrone dimaleate
BBR 2778
Pixuvir
Pixantrone
Plinabulin
NPI-2358

Plitidepsin
Dehydrodidemnin B

Aplidin R Aplidine
Ponatinib
AP24534

Pritumumab


Quarfloxin
CX-3543

Quizartinib
AC220
AC010220

Racotumomab
1E10

Radium223 Chloride

Alpharadin
Radretumab


Ramucirumab
IMC-1121b
IMC 1121B
LY3009806

Ranagengliotucel-T

Glionix
Ranpirnase
Formerly P-30 protein
Onconase
Regorafenib
BAY 73-4506

Resminostat
4SC-201
BYK408740

Retaspimycin hydrochloride
IPI-504
MEDI-561

Ridaforolimus
AP23573
MK-8669

Rigosertib sodium
ON 01910.Na
Estybon
Rindopeptimut
PF-04948568
PF4948568
CDX-110
ALT-110

Rilotumumab
AMG 102

Rituximab

Rituxan
Robatumumab
SCH 717454

Romidepsin

Istodax
Ropidoxuridine
IPdR

Rucaparib
AG-14447

Rucaparib phosphate
AG014699
PF01367338

Ruxolitinib (phosphate)
INC424
INCB018424 (salt)

Sagopilone
DE-03757
ZK 219477
SHY03757,
SH-Y03757A
ZK-219477
ZK-epothilone BAY86-5302
ZK-EPO
Salirasib
farnesyl thiosalicylic acid

Samalizumab
ALXN6000

Sapacitabine
CYC682
CS-682

Saracatinib
AZD0530

Saracatanib fumarate
AZD0530 fumarate

Saridegib
IPI-926

Satumomab pendetide


Seliciclib
R-roscovitine CYC-202

Selumetinib
AZD6244
ARRY-142886
ARRY-886

Selumetinib sulfate
AZD6244 Hydrogen Sulfate

Semaxinib
SU5416

Sepantronium (bromide)
YM155

Sibrotuzumab


Siltuximab
CNTO-328

Sivifene
A-007

Solitomab
MT110

Sorafenib (tosylate)
BAY 43-9006 (BAY 54-9085)
Nexavar
Sotatercept
ACE-011

Squalamine
MSI-1256F
Evizon (ophthalmic)

ALT-801, 264scTCR/IL-2, c264scTCR-IL2
STAR/IL-2
Sulfatinib
HMPL-012

Sunitinib

Sutent
Tabalumab


Tacatuzumab tetraxetan


Talactoferrin alfa, talactoferrin


Talimogene Laherparepvec
OncoVEX GM-CSF, OncoVEXGMCSF, OncoVEXGM-CSF,
JS1 34.5-hGMCSF 47- pA-

Tamoxifen citrate

Soltamox
Tandutinib
MLN0518
MLN518
MLN-518
(formerly CT53518, CT-53518)

Tanespimycin
KOS-953

Tasisulam sodium
LY573636


Tasquinimod
ABR-215050
Tumor Angiogenesis Suppression by Quinolines (TASQ)
Teglanirad chloride
GMX1777
EB1627

Telatinib
BAY 57-9352

Telotristat
LP-778902

Temsirolimus

Torisel
Tenatimomab


Tenifatecan
SN2310

Teprotumumab
RO4858696-000

Theliatinib
HMPL-309

Tigatuzumab
R-161460
TRA-8
CS-1008

Tipapkinogene sovacivec
TG-4001
TG4001
MVA-HPV-IL2
R3484
RO5217790

Tipifarnib
R115777
Zarnestra
Tivantinib
ARQ-650RP
ARQ 650RP
ARQ 197
ARQ197

Tivozanib
AV-951
AV951
Formerly KRN-951

Tosedostat
CHR-2797

Tositumomab


Tozasertib lactate
MK-0457
VX-680

Trametinib
GSK1120212

Trastuzumab

Herceptin
Trastuzumab emtansine
PRO132365
trastuzumab-MCC-DM1
T-DM1
Trastuzumab-DM1
R3502
RG3502

Trebananib
AMG-386

Tremelimumab (formerly ticilimumab)
CP-675,206, CP-675, CP-675206

Ublituximab


Urelumab
BMS-663513

Valrubicin
AD32
Valstar, Valtaxin
Vandetanib
ZD6474
AZD6474
AZD-6474
Caprelsa (formerly Zictifa and Zactima)
Varlitinib
ARRY-334543

Varlitinib tosylate
AR00334543
ARRY-334543
ARRY-543

Vatalanib
PTK787

Veltuzumab
IMMU-106

Veliparib
ABT-888, NSC 737664

Veltuzumab
IMMU-106, hA20, hCD20

Vemurafenib
PLX-4032
RG7204
R7204
RO5185426
Zelboraf
Verubulin
MPC-6827
MX-128495
Azixa
Veltuzumab


Vincristine sulfate liposomes for injection (VSLI)

Marqibo (formerly Onco TCS), Vincristine Optisome
Vinflunine ditartrate
BMS-710485
F-12158
Javlor
Vinorelbine tartrate
ANX-530
Formerly SDP-012
Exelbine
Vintafolide
EC145

Vismodegib
GDC-0449
Cur-691
RG3616
HhAntag
Volasertib
BI6727

Volociximab


Volitinib
HMPL-504

Vorinostat

Zolinza
Vosaroxin
SNS-595
SPC-595, Fformerly AG-7352,
Formerly voreloxin

Votumumab


Zalutumumab
HuMax-EGFr
2F8

Zanolimumab


Zatuximab


Zibotentan
ZD4054





1 commentaire:

  1. Teglarinad chloride, also known as GMX1777, is a water-soluble prodrug of a cyanoguanidine compound with potential antineoplastic activity. In vivo, teglarinad chloride is rapidly converted into active drug through hydrolytic cleavage of a carbonate ester bond. Teglarinad chloride

    RépondreSupprimer